Novel Therapeutic Approaches with DNA Damage Response Inhibitors for Melanoma Treatment
Targeted therapies against components of the mitogen-activated protein kinase (MAPK) pathway and immunotherapies, which block immune checkpoints, have shown important clinical benefits in melanoma patients. However, most patients develop resistance, with consequent disease relapse. Therefore, there...
| Published in: | Cells |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-04-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/11/9/1466 |